Recently, the delivery of the Beclin-1 gene was shown to induce autophagy and reduce amyloid and α-synuclein pathology in mouse models of AD and Parkinson/Lewy Body diseases, respectively (Pickford et al., 2008; Spencer et al., 2009). This evidence concerns the gene BECN1 and Alzheimer disease.